NCT06055569 Efficacy of Rehabilitation Using Action Observation and Muscle Stimulation in Post-stroke Patients.
| NCT ID | NCT06055569 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Don Carlo Gnocchi Onlus |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-11-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2023-11-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Stroke is the third most common cause of disability worldwide and leads to upper limb motor disease in more than half of people affected. Recent data demonstrate that upper limb rehabilitation can be pursued using techniques such as the observation of action (Action Observation Therapy - AOT) or the stimulation of limb musculature using surface electrodes (Neuromuscular Electrical Stimulation - NMES). To date, no rehabilitation studies used both the treatments (AOT-NMES) for the rehabilitation of upper limb after stroke. The goal of this clinical trial is to study the efficacy of this combined approach (AOT-NMES) in people who developed upper limb motor impairment after stroke. The main question this study aims to answer is if the rehabilitation performed using both action observation and neuromuscular stimulation has an higher efficacy than the use of AOT alone and higher than the observation of non-motor stimuli. Participants will be people with upper limb impairment after stroke and will perform 15 rehabilitation sessions (5/week, 3 weeks, 60 minutes each). Each participant will be casually included in one of following three rehabilitation groups: * Action observation associated with neuromuscular stimulation (AOT-NMES, experimental condition): they will observe upper limb movements while their arm muscles will be stimulated. After the observation phase they will try to perform the same movements with the impaired arm. * Action observation alone (AOT): subjects will observe upper limb movements and after the observation phase then they will try to execute them with the impaired arm. * Motor-neutral observation (MNO): subjects will observe non-movement videos and after the observation phase they will try to execute upper limb movements with the impaired arm. Each participant will be evaluated for motor function before and after rehabilitation treatment and researchers will compare the motion improvement between the groups to assess the efficacy of AOT-NMES over other treatments.
Eligibility Criteria
Inclusion Criteria: * Age over 18 years; * Upper arm motor impairment after unilateral stroke as verified by MRI or CT; * Two weeks up to 6 months after stroke; * Grading of upper arm motor impairment\>2 at Medical Research Council scale (MRC). Exclusion Criteria: * Neurological/orthopedic issues that would interfere with upper limb exercises; * Presence of any medical condition that represents a contraindication to Magnetic Resonance Imaging (MRI) examination or to Transcranial Magnetic Stimulation (TMS); * Presence of dermatologic issues that will interfere with neuromuscular stimulator; * Presence of electronic subcutaneous implants; * Presence of peripheral neuropathy; * Epilepsy; * Pregnancy; * Presence of severe cognitive impairment, including language comprehension detected during the neurological evaluation.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06055569 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06055569 currently recruiting?
Yes, NCT06055569 is actively recruiting participants. Contact the research team at mcabinio@dongnocchi.it for enrollment information.
Where is the NCT06055569 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06055569 clinical trial?
NCT06055569 is sponsored by Fondazione Don Carlo Gnocchi Onlus. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.